Nothing Special   »   [go: up one dir, main page]

MX347373B - Soluciones anti-inflamatorias estables para inyección. - Google Patents

Soluciones anti-inflamatorias estables para inyección.

Info

Publication number
MX347373B
MX347373B MX2014001368A MX2014001368A MX347373B MX 347373 B MX347373 B MX 347373B MX 2014001368 A MX2014001368 A MX 2014001368A MX 2014001368 A MX2014001368 A MX 2014001368A MX 347373 B MX347373 B MX 347373B
Authority
MX
Mexico
Prior art keywords
injection
stable anti
inflammatory
inflammatory solutions
solutions
Prior art date
Application number
MX2014001368A
Other languages
English (en)
Other versions
MX2014001368A (es
Inventor
R Gombotz Wayne
A Demopulos Gregory
Rong Shen Hui
Original Assignee
Omeros Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47627326&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX347373(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Omeros Corp filed Critical Omeros Corp
Publication of MX2014001368A publication Critical patent/MX2014001368A/es
Publication of MX347373B publication Critical patent/MX347373B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)

Abstract

La presente invención se relaciona con formulaciones de líquido estable de ketoprofeno, amitriptilina y oximetazolina.
MX2014001368A 2011-08-04 2012-08-03 Soluciones anti-inflamatorias estables para inyección. MX347373B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161515234P 2011-08-04 2011-08-04
PCT/US2012/049463 WO2013020021A1 (en) 2011-08-04 2012-08-03 Stable anti-inflammatory solutions for injection

Publications (2)

Publication Number Publication Date
MX2014001368A MX2014001368A (es) 2014-06-11
MX347373B true MX347373B (es) 2017-04-25

Family

ID=47627326

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014001368A MX347373B (es) 2011-08-04 2012-08-03 Soluciones anti-inflamatorias estables para inyección.

Country Status (21)

Country Link
US (3) US20130035362A1 (es)
EP (1) EP2739266B1 (es)
JP (2) JP6174579B2 (es)
KR (1) KR101951064B1 (es)
CN (1) CN103957886B (es)
AR (1) AR089203A1 (es)
AU (1) AU2012289968B2 (es)
BR (1) BR112014002631B1 (es)
CA (1) CA2844152C (es)
CL (1) CL2014000267A1 (es)
DK (1) DK2739266T3 (es)
ES (1) ES2600153T3 (es)
HK (1) HK1198911A1 (es)
IL (1) IL230779B (es)
MX (1) MX347373B (es)
NZ (1) NZ621484A (es)
PL (1) PL2739266T3 (es)
PT (1) PT2739266T (es)
RU (1) RU2635521C2 (es)
WO (1) WO2013020021A1 (es)
ZA (1) ZA201401344B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110152005B (zh) 2013-03-15 2023-08-04 通尼克斯制药控股有限公司 环苯扎林盐酸盐和阿米替林盐酸盐的低共熔混合物配制剂
US10646574B2 (en) * 2014-07-21 2020-05-12 Board Of Regents, The University Of Texas System Formulations of intraarticular pharmaceutical agents and methods for preparing and using the same
TWI809304B (zh) 2014-12-01 2023-07-21 奥默羅斯公司 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液
US20170049134A1 (en) * 2015-08-18 2017-02-23 Empire Technology Development Llc Meat tendering using food grade natural products for reducing muscle contraction
JP7023690B2 (ja) 2017-12-06 2022-02-22 株式会社東芝 道路維持管理システム、道路維持管理方法及びコンピュータプログラム
US20220347122A1 (en) * 2019-03-15 2022-11-03 Ftf Pharma Private Limited Solutions for oral dosage
JP7008887B2 (ja) 2019-11-01 2022-01-25 三菱電機株式会社 劣化状態判定装置、劣化状態検査システム、及び、劣化状態検査方法
FR3123563A1 (fr) * 2021-06-03 2022-12-09 Algotherapeutix Utilisation de l’amitriptyline et/ou l’un de ses sels pharmaceutiquement acceptable comme agent conservateur
CN116165306B (zh) * 2023-04-25 2023-11-17 湖南九典制药股份有限公司 酮洛芬凝胶贴膏中有关物质的分析测定方法及应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5624893A (en) * 1993-10-14 1997-04-29 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation
IT1269583B (it) * 1994-04-26 1997-04-08 Bayer Italia Spa Preparazioni farmaceutiche a base di una soluzione di ketoprofene in capsule di gelatina molle e metodo per la loro produzione
ATE532530T1 (de) * 1994-12-12 2011-11-15 Omeros Corp Bespüllungslösung und deren verwendung zur perioperativen hemmung von schmerzen, entzündungen und/oder spasmen an einer gefässstruktur
US7091181B2 (en) * 1994-12-12 2006-08-15 Omeros Corporation Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors
KR100517210B1 (ko) * 1994-12-12 2006-06-07 오메로스 코포레이션 통증,염증및경련억제용관주용액
IT1277741B1 (it) * 1995-12-28 1997-11-12 Dompe Spa Composizioni farmaceutiche parenterali contenenti sali di alchilammonio di acidi 2-arilpropionici
US7973068B2 (en) * 1998-10-20 2011-07-05 Omeros Corporation Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
US7022740B2 (en) * 2004-04-29 2006-04-04 Leonard Mackles Lubricious ophthalmic solutions
US20070053868A1 (en) * 2005-03-08 2007-03-08 Banner Pharmacaps, Inc. Solvent system for enhancing the solubility of pharmaceutical agents
US8790696B2 (en) * 2005-05-20 2014-07-29 Omeros Corporation Cyclooxygenase inhibitor and calcium channel antagonist compositions and methods for use in urological procedures
CN101460060A (zh) * 2006-03-01 2009-06-17 特莱斯特拉塔公司 局部治疗焦油响应性皮肤病用的组合物和方法
WO2008098019A2 (en) * 2007-02-05 2008-08-14 Carbylan Biosurgery, Inc. Polymer formulations for delivery of bioactive agents
WO2008115572A1 (en) * 2007-03-21 2008-09-25 Theraquest Biosciences, Inc. Methods and compositions of nsaids
EP3578178A1 (en) * 2011-02-15 2019-12-11 Aclaris Therapeutics, Inc. Pharmaceutical composition comprising oxymetazoline

Also Published As

Publication number Publication date
EP2739266A1 (en) 2014-06-11
EP2739266A4 (en) 2014-12-31
DK2739266T3 (en) 2016-10-03
ZA201401344B (en) 2016-10-26
HK1198911A1 (zh) 2015-06-19
KR20140057579A (ko) 2014-05-13
CL2014000267A1 (es) 2014-08-29
US20160166696A1 (en) 2016-06-16
JP2014521694A (ja) 2014-08-28
IL230779B (en) 2019-05-30
KR101951064B1 (ko) 2019-02-21
RU2014108159A (ru) 2015-09-10
ES2600153T3 (es) 2017-02-07
EP2739266B1 (en) 2016-07-27
JP2017014288A (ja) 2017-01-19
PL2739266T3 (pl) 2017-07-31
WO2013020021A1 (en) 2013-02-07
BR112014002631B1 (pt) 2022-04-19
CN103957886B (zh) 2016-03-30
AU2012289968B2 (en) 2014-01-16
JP6174579B2 (ja) 2017-08-02
NZ621484A (en) 2016-05-27
US20130035362A1 (en) 2013-02-07
AU2012289968A1 (en) 2013-03-28
CN103957886A (zh) 2014-07-30
AR089203A1 (es) 2014-08-06
IL230779A0 (en) 2014-03-31
PT2739266T (pt) 2016-10-04
US20180344855A1 (en) 2018-12-06
CA2844152C (en) 2020-04-14
MX2014001368A (es) 2014-06-11
BR112014002631A2 (pt) 2017-03-07
CA2844152A1 (en) 2013-02-07
RU2635521C2 (ru) 2017-11-13

Similar Documents

Publication Publication Date Title
MX2014001368A (es) Soluciones anti-inflamatorias estables para inyección.
PH12015500850A1 (en) Stable preservative-free mydriatic and anti-inflammatory solutions for injection
UY34587A (es) Formulaciones estabilizadas que contienen anticuerpos antiang2
DK2882850T3 (da) System for preparation of adipose-derived stem cells
CL2014003370A1 (es) Composición acuosa estable de anticuerpos anti-baffr; y dispositivo de suministro de la composición.
AU2012265219A8 (en) Compounds containing hydrido-tricyano-borate anions
BR112015004936A2 (pt) composição farmacêutica revestida contendo regorafenib
CR20130539A (es) Triazolopiridinas
EP2852588B8 (en) Hydantoin derivatives as kv3 inhibitors
GEP201706710B (en) Imidazopyridazine derivatives as gabaa receptor modulators
IT1402018B1 (it) Formulazioni per il trattamento delle affezioni delle prime vie respiratorie.
CO7141434A2 (es) Nueva forma de dosificación formulación de abediterol
CO7151478A2 (es) Formulaciones estabilizadas que contienen anticuerpos anti-dll4
ITTO20110268A1 (it) Composizione di maquillage.
MX351610B (es) Sales acidas de adicion de 5alfa-hidroxi-6beta-[2-(1h-imidazol-4-i l)etilamino]colestan-3beta-ol.
UY34154A (es) Dosificación y administración de anticuerpos anti-erbb3 en combinación con paclitaxel.
EA201492280A1 (ru) Стабильный состав пексиганана
EA201400444A1 (ru) Производные 2-оксопиперидинила
IT1399492B1 (it) Composizioni farmaceutiche effervescenti contenenti n-acetilcisteina.
UY35004A (es) Forma amorfa estabilizada de la agomelatina, su procedimiento de preparación y las composiciones farmacéuticas que la contienen
BR112013027391A2 (pt) formulação farmacêutica, frasco e kit
BR112013027390A2 (pt) formulação farmacêutica
BR112013025766A2 (pt) composições farmacêuticas de liberação modificada de desvenlafaxina
TH1201001042B (th) สูตรผสมเชิงเภสัชกรรมที่เข้มข้นสูง, ซึ่งเสถียรของแอนติ-CD20 แอนติบอดี (anti-CD20 antibody)
UA70513U (ru) Лекарственная форма на основе коры осины

Legal Events

Date Code Title Description
FG Grant or registration